Page 161 - Flipbook January Board
P. 161

Robert Packer Hospital





                              Key Indicators – Oncology Services





                                                Month - to - Date                                                                                                          Year - to - Date
                                Actual          Prior Year              Var        Var %                                                                 Actual          Prior Year               Var           %

                                                                                                           Medical Oncology:
                                      71                  106             (35) -33.0%                            New Patients                                447                  457                (10)     -2.2%
                                                                                                                    Infusions:

                                    544                   550               (6)     -1.1%                      Chemo Infusions                            3,958                3,518                440       12.5%
                                    695                   783             (88) -11.2%                       Non-Chemo Infusions                           4,975                4,711                264         5.6%
                                 1,239                1,333               (94)      -7.1%                        Total Infusions                          8,933                8,229                704         8.6%



                                    177                   130              47       36.2%                         Oral Chemo                              1,013                   829               184       22.2%

                                    717                   679              38         5.6%                    Established Visits                          4,880                4,035                845       20.9%


                                                                                                          Radiation Oncology

                                    525                   508              17         3.3%                Number of Treatments                            3,512                3,058                454       14.8%
                                      20                    33            (13) -39.4%                  Number of New & Consults                              190                  193                  (3)    -1.6%

                                      34                    31               3        9.7%                         New Starts                                223                  205                 18        8.8%
                                      26                    25               1        4.0%                Ave # Pt. Treated/Day                                28                   24                  4     16.7%




                                                Month - to - Date                                                                                                             Year - to - Date

                                Actual             Budget               Var       Var %                                                                     Actual            Budget                Var        Var %

                               10,962 $               7,694 $ 3,268                42.5%           Total CTS - Gross Revenue                           $ 67,186 $               50,855 $ 16,331 32.1%

                                 2,927 $              2,158 $           768        35.6%           Total CTS - Est Net Revenue                         $ 17,926 $               14,250 $ 3,676 25.8%





                                 1,667 $              1,021 $           646        63.2%           CTS Pharmaceutical Exp                              $ 9,645 $                  6,369 $ 3,276 51.4%

                                    57%                  47%                                       CTS Pharm Exp as % of Net Rev                               54%                   45%
   156   157   158   159   160   161   162   163   164   165   166